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Abstract
Purpose To demonstrate that a euploid embryo derived
from an oocyte with reciprocal aneuploid polar bodies is
capable of producing a chromosomally normal child.
Methods A case report of maternal MI error compensation
where single nucleotide polymorphism (SNP) microarray
based comprehensive chromosome screening (CCS) was
performed on the 1st and 2nd polar body, the resulting
embryo, and newborn DNA.
Results CCS performed after embryo transfer identified a
chromosomally normal embryo that resulted from an oocyte
with reciprocal aneuploid polar bodies. The first polar body
was found to be missing a single chromatid derived from
chromosome 21 and the second polar body possessed an
extra chromatid derived from chromosome 21. Compensa-
tion of the maternal meiotic error was verified by CCS
analysis of a trophectoderm biopsy from the resulting blas-
tocyst which was euploid for all 23 pairs of chromosomes.
DNA fingerprinting and CCS of the resulting newborn
confirmed a chromosomally normal child, demonstrating
the developmental potential of an oocyte with reciprocal
aneuploid polar bodies.
Conclusions This is the first case report demonstrating the
reproductive potential of a chromosomally normal embryo
derived from an oocyte which had undergone meiosis I
error. Systematic investigation into the frequency of meiosis
I error compensation and the negative predictive value of
polar body aneuploidy screening for reproductive potential
should be conducted in order to confirm clinical relevance.
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Introduction
There is growing interest in the development of new com-
prehensive methods of 24-chromosome aneuploidy screen-
ing (CCS) to reduce the time to pregnancy and the incidence
of miscarriage in patients with infertility. Indeed, preclinical
validation of array based methodologies have been encour-
aging [1–6] and clinical results of comprehensive methods
have been promising [7, 8]. These studies have now led to
the development of a number of randomized controlled trials
(RCTs) to assess clinical efficacy. Most of the ongoing
RCTs (www.clinicaltrials.gov ID numbers, NCT01194531,
Capsule SNP microarray based analysis identified a reciprocal single
chromatid abnormality of chromosome 21 in the 1st and 2nd polar body
of an oocyte which produced a euploid embryo and a chromosomally
normal child. Identification of reciprocal polar body aneuploidy in
oocytes requires further clinical investigation as they can possess
potential to become healthy children.
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trials.com ID number ISRCTN37972669) involve evalua-
tion of array comparative genomic hybridization (aCGH) or
single nucleotide polymorphism (SNP) array technology of
embryonic biopsies (cleavage or blastocyst). In contrast, the
European Society of Human Reproduction and Embryology
(ESHRE) Preimplantation Genetic Screening (PGS) Task
Force has initiated a multicenter RCT to characterize the
utility of polar body aCGH [9]. Each approach has a variety
of theoretical limitations that are both technical and biolog-
ical in nature [10].
One challenge associated with polar body chromosome
screening is related to making the decision to discard oocytes
with aneuploid polar bodies or based on aneuploidy in the 1st
polar body alone [11, 12]. In a preclinical study, the ESHRE
PGSTaskForceaCGHdataindicatedthat6ofthe138oocyte/
polar body pairs (4 %) displayed euploidy in the resulting
zygotes despite aneuploidy in the corresponding polar bodies
[5]. Another study, using polar body metaphase (m)CGH,
reported a similar phenomenon at a frequency of 1.7 % (2 of
113) [13]. In the latter study the errors could be explained
through compensation of meiosis I premature separation of
sisterchromatids(PSSC)duringmeiosisII.Specifically,when
the 1st polarbodyacquiredonlyonechromatid frommeiosisI
and the 2nd polar body acquired the corresponding extra
chromatid from meiosis II, the resulting zygote could be
euploid. Likewise, an extra chromatid in the 1st polar body
and a corresponding missing chromatid in the 2nd polar body
could also lead to a euploid zygote. However, the ability of
euploid zygotes derived from oocytes with reciprocal aneu-
ploid polar bodies to produce healthy offspring is unknown.
This case report presents the first evidence to support the
potential for reproductive competence of oocytes with recip-
rocal aneuploid polar bodies.
Materials and methods
This specific case came from a clinical study to determine the
predictive value of DNA fingerprinting of polar bodies and
embryoniccells(ClinicalTrials.govID#NCT01219517).This
study was performed with institutional review board approval
and patient consent. A couple presenting for infertility treat-
ment based on advanced maternal age (41 years) with normal
ovarianreserveandnomalefactorinfertilitywasrecruitedand
consented into this IRB approved study. The female partner
underwent a down regulation antagonist ovarian stimulation
protocol. A total of16 oocytes were retrieved, 11 matured and
10fertilizedbyintracytoplasmicsperminjection.Allfertilized
zygotes were cultured in sequential media to the blastocyst
stage following 1st (Day 0) and 2nd (Day 1) polar body
biopsy as previously described [14]. A trophectoderm biopsy
was performed on day 5 of embryonic development as
previously described [7] prior to a fresh day 5 blastocyst
transfer. A twin clinical pregnancy was confirmed by ultra-
sound with fetal heart tones. Both female babies were deliv-
ered liveborn with no complications.
The case was identified using a validated method of CCS
involving whole genome amplification and SNP microarray
analysis on sequentially biopsied 1st and 2nd polar bodies,
and trophectoderm cells as previously described [1, 7, 14].
Upon delivery, newborn buccal DNA was obtained to de-
termine the chromosome constitution and to perform DNA
fingerprinting to confirm genetic identity to the 1st polar
body and trophectoderm of the transferred embryo as previ-
ously described [14–16]. First polar bodies from sibling
oocytes and trophectoderm from supernumerary cryo-
preserved (non-transferred) sibling embryos were used as
controls for predicting the relationship between each of the
newborn females. For 1st polar body based fingerprinting, a
40 % threshold was applied providing 100 % sensitivity and
specificity for distinguishing siblings and identifying iden-
tical relationships from the 1st polar body as previously
published [15]. First polar bodies with less than 40 % iden-
tity to newborn DNA are considered self relationships. For
trophectoderm biopsy based fingerprinting, a 50 % thresh-
old was applied based on a similar 100 % predictive value
for distinguishing siblings and identifying identical relation-
ships from a single blastomere or trophectoderm biopsy
[16]. Trophectoderm with greater than 50 % identity to
newborn DNA are considered self relationships.
Results
The 1st polar body was identified as possessing a loss of
genetic material from chromosome 21 (Fig. 1). The 2nd
polar body was found to possess a gain of genetic material
from chromosome 21 (Fig. 1). All remaining chromosomes
in both polar bodies were observed as euploid. Analysis of
the resulting blastocyst stage embryo trophectoderm biopsy
revealed euploidy for all 23 pairs of chromosomes (Fig. 1).
The pattern of copy number in the three samples from this
oocyte/embryo was consistent with PSSC of chromosome
21 during meiosis I, with subsequent compensation by mei-
osis II segregation of the extra chromatid to the 2nd polar
body rather than the remaining oocyte. Delivery of a healthy
female with a normal number of chromosomes was con-
firmed by CCS analysis of buccal cells from the newborn
(Fig. 1).
In order to confirm the genetic relationships between
biopsied samples and newborn DNA, two independent
methods of DNA fingerprinting were employed. First, polar
body and newborn buccal DNA fingerprinting confirmed
that the 1st polar body from transferred embryo #1 (with
loss of a single chromosome 21 chromatid) was a genetic
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“B” (Fig. 2a). Importantly, newborn B matched only this
particular 1st polar body while failing to match 3 known
sibling oocyte derived 1st polar bodies (embryo #3, 4, and
5) and the other sibling oocyte, embryo 2 that was trans-
ferred. The same observations were made for the relation-
ships between the 1st polar body from transferred embryo
#2 and newborn A.
As a second measure of identity, trophectoderm and
newborn buccal DNA fingerprinting confirmed that trans-
ferred embryo #1 (derived from the oocyte with reciprocal
aneuploid polar bodies) was a genetic match with one of the
two newborn DNA samples, newborn “B” (Fig. 2b). New-
born B matched only this particular trophectoderm biopsy
while failing to match 3 known sibling embryo derived
trophectoderm biopsies (sibling cryopreserved embryos #3,
Fig. 1 An oocyte with reciprocal aneuploid polar bodies is capable of
producing a chromosomally normal child. Diagrams (left) indicate the
segregation pattern for chromosome 21 with the corresponding SNP
microarray based copy number plots (right) of the oocyte’s 1st and 2nd
polar body, a trophectoderm biopsy from the resulting embryo, and
buccal cells from the newborn derived after embryo transfer. GV 0
germinal vesicle, PB 0 polar body, CN 0 copy number
J Assist Reprod Genet (2012) 29:533–537 5354, and 5) and the other transferred embryo (embryo #2). The
same observations were made for the relationships between
the trophectoderm from transferred embryo #2 and newborn
A. Furthermore, the relationships identified between both
the 1st polar bodies and the trophectoderm biopsies with
newborn DNAs were 100 % consistent with each other.
Discussion
These results provide a definitive proof-of-principle that a
euploid zygote derived from an oocyte with reciprocal an-
euploid polar bodies is capable of producing a chromosom-
ally normal child. This was demonstrated with the use of a
single cell CCS methodology proven to provide 98.6 %
accuracy of 24 chromosome copy number assignment and
no false positives [1]. In addition, it is highly unlikely that
the 1st polar body would have a false positive loss of the
same chromosome found to have a false positive gain in the
2nd polar body (probability of 0.03 %). Chromosome anal-
yses demonstrated that the trophectoderm biopsy from the
blastocyst and buccal cells from the newborn were euploid.
Finally, a genetic match for the 1st polar body and the
newborn, and for the trophectoderm biopsy and the same
newborn was confirmed using two independent DNA fin-
gerprinting methodologies that have been shown to provide
a 100 % level of certainty for polar body and embryo biopsy
DNA [15, 16].
Interestingly, prior to the completion of meiosis II, this
oocyte was at risk of developing into an embryo with
Fig. 2 Results of genetic
fingerprinting to confirm the
preimplantation genetic origin
of newborn DNA. a 1st polar
body DNA based fingerprinting
illustrating a match between
transferred embryo #1 and
newborn B, and transferred
embryo #2 and newborn A. The
cutoff of 40 % is indicated with
a black bar and is based on
previous publication [15].
Similarities below 40 % are
considered a match and above a
sibling. b Trophectoderm DNA
based fingerprinting illustrating
a match between transferred
embryo #1 and newborn B, and
transferred embryo #2 and
newborn A. The cutoff of 50 %
is indicated with a black bar and
is based on previous publication
[16]. Similarities above 50 %
are considered a match and
below a sibling. In each type of
fingerprinting, transferred
embryo #1 was the one which
possessed reciprocal aneuploid
polar bodies, and was the
oocyte/embryo that matched
newborn B. Embryo #3, 4 and 5
served as known sibling control
embryos since they were not
transferred
536 J Assist Reprod Genet (2012) 29:533–537trisomy 21, with the potential to result in delivery of a child
with Down syndrome. However, as a result of the extra
chromatid segregating to the 2nd polar body rather than
the oocyte, the subsequent embryo acquired a euploid kar-
yotype. This may be a random event with an equal propor-
tion of oocytes inheriting either an abnormal or normal
number of chromosomes following a meiosis I PSSC error
[17]. However, this has yet to be supported with experimen-
tal evidence. Alternatively, it is intriguing to hypothesize
that this process could be influenced by the microenviron-
ment of the developing oocyte towards the favorable out-
come of euploidy.
Given that this case report has demonstrated the repro-
ductive potential of a euploid embryo derived from an
oocyte with reciprocal aneuploid polar bodies, it questions
discarding an oocyte based solely on the observation of
reciprocal aneuploidy in the polar bodies or based on iden-
tification of aneuploidy in the first polar body alone [11, 12].
Instead, analysis of aneuploidy in the resulting embryo
should be performed to ascertain the frequency of develop-
ment of euploid embryos from oocytes with reciprocal an-
euploid polar bodies. This is particularly true given the
estimate that most MI errors are from PSSC and the results
of the present case report. An initial review of SNP micro-
array data from over 1,000 polar body pairs has identified 43
cases (~4 %) in which the 1st and 2nd polar bodies are
perfectly complementary. The prevalence of euploidy in
the embryos resulting from these oocytes now represents
an area of active ongoing research in our own laboratories in
order to estimate the clinical relevance of this phenomenon.
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